tailieunhanh - báo cáo hóa học: " The Cervical Dystonia Impact Profile (CDIP-58): Can a Rasch developed patient reported outcome measure satisfy traditional psychometric criteria?"

Tuyển tập các báo cáo nghiên cứu về sinh học được đăng trên tạp chí hóa học quốc tế đề tài : The Cervical Dystonia Impact Profile (CDIP-58): Can a Rasch developed patient reported outcome measure satisfy traditional psychometric criteria? | BioMed Central Health and Quality of Life Outcomes Research The Cervical Dystonia Impact Profile CDIP-58 Can a Rasch developed patient reported outcome measure satisfy traditional psychometric criteria Stefan J Cano1 2 Thomas T Warner3 Alan J Thompson1 Kailash P Bhatia4 Ray Fitzpatrick5 and Jeremy C Hobart 2 1 Open Access Address 1Neurological Outcome Measures Unit Institute of Neurology University College London Queen Square London UK 2Department of Clinical Neuroscience Room N16 ITTC Building Peninsula College of Medicine and Dentistry Tamar Science Park Davy Road Plymouth UK 3Department of Clinical Neurosciences Royal Free University College Medical School London UK 4Sobell Department of Motor Neuroscience and Movement Disorders Institute of Neurology University College London Queen Square London UK and 5Department of Public Health University of Oxford Old Road Campus Roosevelt Drive Headington Oxford UK Email Stefan J Cano - scano@ Thomas T Warner - twarner@ Alan J Thompson - Kailash P Bhatia - kbhatia@ Ray Fitzpatrick - Jeremy C Hobart - Corresponding author Published 6 August 2008 Received 8 December 2007 Health and Quality of Life Outcomes 2008 6 58 doi 86 1477-7525-6-58 Accepted 6 August 2008 This article is available from http content 6 1 58 2008 Cano et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract Background The United States Food and Drug Administration FDA are currently producing guidelines for the scientific adequacy of patient reported outcome measures PROMs in clinical trials which will have implications for the selection of scales used in future .